Gene · 4299
Papers2,225
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,225
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| (Tn5-)FISH-based imaging in the era of 3D/spatial genomics. | Biophys Rep | 2023 | 37426200 | PubTator, text mining | PubMed |
| Design and advanced characterization of quercetin-loaded nano-liposomes prepared by high-pressure homogenization. | Food Chem | 2023 | 37418880 | PubTator, text mining | PubMed |
| Identifying childhood leukemia with an excess of hematological malignancies in first-degree relatives in Brazil. | Front Oncol | 2023 | 37416530 | PubTator, text mining | PubMed |
| Biomolecular Condensates in Myeloid Leukemia: What Do They Tell Us? | Hemasphere | 2023 | 37388925 | PubTator, text mining | PubMed |
| How chromosomal translocations arise to cause cancer: Gene proximity, trans-splicing, and DNA end joining. | iScience | 2023 | 37378346 | PubTator, text mining | PubMed |
| EEG and peripheral markers of viewer ratings: a study of short films. | Front Neurosci | 2023 | 37378009 | PubTator, text mining | PubMed |
| Assessment of the Effects of Structural Modification of Gastrodia elata Polysaccharide on Anti-Breast Cancer Activity Using Asymmetrical Flow Field-Flow Fractionation. | Molecules | 2023 | 37375222 | PubTator, text mining | PubMed |
| MTHFR act as a potential cancer biomarker in immune checkpoints blockades, heterogeneity, tumor microenvironment and immune infiltration. | Discov Oncol | 2023 | 37354330 | PubTator, text mining | PubMed |
| Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development. | Front Cell Dev Biol | 2023 | 37325571 | PubTator, text mining | PubMed |
| [AF4/FMR2 and IL-10 gene single nucleotide polymorphisms are correlated with disease susceptibility and immune infiltration in ankylosing spondylitis]. | Nan Fang Yi Ke Da Xue Xue Bao | 2023 | 37313815 | PubTator, text mining | PubMed |
| Using Drosophila to identify naturally occurring genetic modifiers of amyloid beta 42- and tau-induced toxicity. | G3 (Bethesda) | 2023 | 37311212 | PubTator, text mining | PubMed |
| Venetoclax durable response in adult relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia with JAK/STAT pathway alterations. | Front Cell Dev Biol | 2023 | 37287455 | PubTator, text mining | PubMed |
| The emerging roles and mechanism of N6-methyladenosine (m6A) modifications in urologic tumours progression. | Front Pharmacol | 2023 | 37284313 | PubTator, text mining | PubMed |
| Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins. | Proc Natl Acad Sci U S A | 2023 | 37276407 | PubTator, text mining | PubMed |
| Targeting CDK9 with selective inhibitors or degraders in tumor therapy: an overview of recent developments. | Cancer Biol Ther | 2023 | 37272701 | PubTator, text mining | PubMed |
| Analysis of Silicon Quantum Dots and Serum Proteins Interactions Using Asymmetrical Flow Field-Flow Fractionation. | Langmuir | 2023 | 37225422 | PubTator, text mining | PubMed |
| TMT proteomics analysis reveals the mechanism of bleomycin-induced pulmonary fibrosis and effects of Ginseng honeysuckle superfine powdered tea. | Chin Med | 2023 | 37221600 | PubTator, text mining | PubMed |
| Post-translational modifications of histones: Mechanisms, biological functions, and therapeutic targets. | MedComm (2020) | 2023 | 37220590 | PubTator, text mining | PubMed |
| The Prognostic Effect of CDKN2A/2B Gene Deletions in Pediatric Acute Lymphoblastic Leukemia (ALL): Independent Prognostic Significance in BFM-Based Protocols. | Diagnostics (Basel) | 2023 | 37174980 | PubTator, text mining | PubMed |
| Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity. | Neoplasia | 2023 | 37148657 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4299/papers?page=9